Digital interventions for the management of chronic obstructive pulmonary disease
Authors:
- 19 April 2021
- journal article
- review article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (4) , CD013246
Abstract
Background Chronic obstructive pulmonary disease (COPD) is associated with dyspnoea, cough or sputum production (or both) and affects quality of life and functional status. More efficient approaches to alternative management that may include patients themselves managing their condition need further exploration in order to reduce the impact on both patients and healthcare services. Digital interventions may potentially impact on health behaviours and encourage patient engagement. Objectives To assess benefits and harms of digital interventions for managing COPD and apply Behaviour Change Technique (BCT) taxonomy to describe and explore intervention content. Search methods We identified randomised controlled trials (RCTs) from the Cochrane Airways Trials Register (date of last search 28 April 2020). We found other trials at web‐based clinical trials registers. Selection criteria We included RCTs comparing digital technology interventions with or without routine supported self‐management to usual care, or control treatment for self‐management. Multi‐component interventions (of which one component was digital self‐management) compared with usual care, standard care or control treatment were included. Data collection and analysis We used standard Cochrane methods. Two review authors independently selected trials for inclusion, extracted data, and assessed risk of bias. Discrepancies were resolved with a third review author. We assessed certainty of the evidence using the GRADE approach. Primary outcomes were impact on health behaviours, self‐efficacy, exacerbations and quality of life, including the St George's Respiratory Questionnaire (SGRQ). The minimally important difference (MID) for the SGRQ is 4 points. Two review authors independently applied BCT taxonomy to identify mechanisms in the digital interventions that influence behaviours. Main results Fourteen studies were included in the meta‐analyses (1518 participants) ranging from 13 to 52 weeks duration. Participants had mild to very severe COPD. Risk of bias was high due to lack of blinding. GRADE ratings were low to very low certainty due to lack of blinding and imprecision. Common BCT clusters identified as behaviour change mechanisms in interventions were goals and planning, feedback and monitoring, social support, shaping knowledge and antecedents. Digital technology intervention with or without routine supported self‐management Interventions included mobile phone (three studies), smartphone applications (one study), and web or Internet‐based (five studies). Evidence is very uncertain about effects on impact on health behaviours as measured by six‐minute walk distance (6MWD) at 13 weeks (mean difference (MD) 26.20, 95% confidence interval (CI) ‐21.70 to 74.10; participants = 122; studies = 2) or 23 to 26 weeks (MD 14.31, 95% CI ‐19.41 to 48.03; participants = 164; studies = 3). There may be improvement in 6MWD at 52 weeks (MD 54.33 95% CI ‐35.47 to 144.12; participants = 204; studies = 2) but studies were varied (very low certainty). There may be no difference in self‐efficacy on managing Chronic Disease Scale (SEMCD) or pulmonary rehabilitation adapted index of self‐efficacy tool (PRAISE). Evidence is very uncertain. Quality of life may be slightly improved on the chronic respiratory disease questionnaire (CRQ) at 13 weeks (MD 0.45, 95% CI 0.01 to 0.90; participants = 123; studies = 2; low certainty), but is not clinically important (MID 0.5). There may be little or no difference at 23 or 52 weeks (low to very low certainty). There may be a clinical improvement on SGRQ total at 52 weeks (MD ‐26.57, 95% CI ‐34.09 to ‐19.05; participants = 120; studies = 1; low certainty). Evidence for COPD assessment test (CAT) and Clinical COPD Questionnaire (CCQ) is very uncertain. There may be little or no difference in dyspnoea symptoms (CRQ dyspnoea) at 13, 23 weeks or 52 weeks (low to very low certainty evidence) or mean number of exacerbations at 26 weeks (low‐certainty evidence). There was no evidence for the number of people experiencing adverse events. Multi‐component interventions Digital components included mobile phone (one study), and web or internet‐based (four studies). Evidence is very uncertain about effects on impact on health behaviour (6MWD) at 13 weeks (MD 99.60, 95% CI ‐15.23 to 214.43; participants = 20; studies = 1). No evidence was found for self‐efficacy. Four studies reported effects on quality of life (SGRQ and CCQ scales). The evidence is very uncertain. There may be no difference in the number of people experiencing exacerbations or mean days to first exacerbation at 52 weeks with a multi‐component intervention compared to standard care. Evidence is very uncertain about effects on the number of people experiencing adverse events at 52 weeks. Authors' conclusions There is insufficient evidence to demonstrate a clear benefit or harm of digital technology interventions with or without supported self‐management, or multi‐component interventions compared to usual care in improving the 6MWD or self‐efficacy. We found there may be some short‐term improvement in quality of life with digital interventions, but there is no evidence about whether the effect is sustained long term. Dyspnoea symptoms may improve over a longer duration of digital intervention use. The evidence for multi‐component interventions is very uncertain and as there is little or no evidence for adverse events, we cannot determine the benefit or harm of these interventions. The evidence base is predominantly of very low certainty with concerns around high risk of bias due to lack of blinding. Given that variation of interventions and blinding is likely to be a concern, future, larger studies are needed taking these limitations in consideration. Future studies are needed to...Keywords
This publication has 88 references indexed in Scilit:
- MIOTIC study: a prospective, multicenter, randomized study to evaluate the long-term efficacy of mobile phone-based Internet of Things in the management of patients with stable COPDInternational Journal of Chronic Obstructive Pulmonary Disease, 2013
- A randomised controlled trial testing a web-based, computer-tailored self-management intervention for people with or at risk for chronic obstructive pulmonary disease: a study protocolBMC Public Health, 2013
- Implementation of self management support for long term conditions in routine primary care settings: cluster randomised controlled trialBMJ, 2013
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- A Systematic Review of Healthcare Applications for SmartphonesBMC Medical Informatics and Decision Making, 2012
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Assessing health status in COPD. A head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ)BMC Pulmonary Medicine, 2012
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Home-Based, Peer-Led Chronic Illness Self-Management Training: Findings From a 1-Year Randomized Controlled TrialThe Annals of Family Medicine, 2009
- Randomized Controlled Trial of an Internet-Based Versus Face-to-Face Dyspnea Self-Management Program for Patients With Chronic Obstructive Pulmonary Disease: Pilot StudyJournal of Medical Internet Research, 2008